Alpha 1 antitrypsin augmentation for alpha 1 antitrypsin deficiency associated lung disease

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effects of alpha 1 antitrypsin augmentation therapy on respiratory disease in people with alpha 1 antitrypsin deficiency.

This is a protocol.

Published:

16 October 2024

Authors:

Glaister P, Hindle Robinson N, Ward A, Bentham C, Crossingham I

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Glaister P, Hindle Robinson N, Ward A, Bentham C, Crossingham I. Alpha 1 antitrypsin augmentation for alpha 1 antitrypsin deficiency associated lung disease (Protocol). Cochrane Database of Systematic Reviews 2024, Issue 10. Art. No.: CD015930. DOI: 10.1002/14651858.CD015930.